title: Coronary artery disease prevention: what's different for women?
abstract: Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk. Exercise, hypertension treatment, smoking cessation and aspirin therapy are effective measures for the primary prevention of coronary artery disease in women. The roles of lipid-lowering agents and hormone replacement therapy in primary prevention are not well established. In secondary prevention, hormone replacement therapy has not been effective in lowering the risk of recurrent myocardial infarction, but several lipid-lowering agents have been shown to reduce this risk and to lower mortality rates in women with known coronary artery disease. Other secondary prevention measures, including aspirin, beta blockers, angiotensin-converting enzyme inhibitors, revascularization and rehabilitation, have proven benefits in women but are underused, especially in minority women. Family physicians should emphasize the use of proven treatments, with particular attention given to underserved populations.
authors: Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee 53226, USA. jbmd@mcw.edu
authors: J
authors: J
authors: Bedinghaus
authors: L
authors: L
authors: Leshan
authors: S
authors: S
authors: Diehr
mesh_terms: D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D006949:Hyperlipidemias / Q000517:prevention & control; D006973:Hypertension / Q000517:prevention & control; D008297:Male; D015995:Prevalence; D011322:Primary Prevention; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects; D014481:United States / Q000453:epidemiology